General Information
Revision date
2021-03-02
Product name
LAFAZYM CLARIFICATION KP
CAS No.
9032-75-1
supplier name
LAFFORT FRANCE SAS
Emergency telephone
Comment
Icons in SDS
Company Information
company name
LAFFORT FRANCE SAS
e-mail address of the competent person responsible for the Safety Data Sheet
info@laffort.com, laffortitalia@laffort.com, laffortusa@laffort.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H334
Hazard statements
Code
Statements
H334
May cause allergy or asthma symptoms or breathing difficulties if inhaled
Section 2
CLP CLASSIFICATION
Respiratory sensitisation, Category 1 H334 Full text of H- and EUH-statements: see section 16
Adverse physicochemical, human health and environmental effects
No additional information available
2.2 Label elements
Labelling according to Regulation (EC) No. 1272/2008 [CLP]
Hazard pictograms
GHS08
Signal word
Danger
Contains
Polygalacturonase enzyme
Hazard statements
H334 - May cause allergy or asthma symptoms or breathing difficulties if inhaled.
Precautionary statements
P261 - Avoid breathing dust, fume, gas, mist, vapours, spray. P280 - Wear protective gloves, protective clothing/eye protection/face protection. P284 - In case of inadequate ventilation wear respiratory protection. P304+P340 - IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing. P342+P311 - If experiencing respiratory symptoms: Call a POISON CENTER or doctor/physician.
Other hazards which do not result in classification
May cause sensitization by inhalation and skin contact. mild eye irritation. mild skin irritation. The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605
